Advertisement

Index by author

September 01, 1996; Volume 50,Issue 3

  1. Sadeghi, H

    1. A fully active nonglycosylated V2 vasopressin receptor.
      G Innamorati, H Sadeghi and M Birnbaumer
      Molecular Pharmacology September 1996, 50 (3) 467-473;

  2. Salvatore, C

    1. Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation.
      F Animati, F Arcamone, M Bigioni, G Capranico, C Caserini, M De Cesare, P Lombardi, G Pratesi, C Salvatore, R Supino and F Zunino
      Molecular Pharmacology September 1996, 50 (3) 603-609;

  3. Schmidt, R R

    1. Structural requirements of sphingosylphosphocholine and sphingosine-1-phosphate for stimulation of activator protein-1 activity.
      A Berger, R Bittman, R R Schmidt and S Spiegel
      Molecular Pharmacology September 1996, 50 (3) 451-457;

  4. Seward, E P

    1. Functional selectivity of orphanin FQ for its receptor coexpressed with potassium channel subunits in Xenopus laevis oocytes.
      H Matthes, E P Seward, B Kieffer and R A North
      Molecular Pharmacology September 1996, 50 (3) 447-450;

  5. Shafferman, A

    1. Interactions of oxime reactivators with diethylphosphoryl adducts of human acetylcholinesterase and its mutant derivatives.
      H Grosfeld, D Barak, A Ordentlich, B Velan and A Shafferman
      Molecular Pharmacology September 1996, 50 (3) 639-649;

  6. Shreeve, S M

    1. Direct evidence for functional coupling of the vasoactive intestinal peptide receptor to Gi3 in native lung membranes.
      N L Diehl, J C Kermode and S M Shreeve
      Molecular Pharmacology September 1996, 50 (3) 624-630;

  7. Siegel, D

    1. Induction of apoptosis by benzene metabolites in HL60 and CD34+ human bone marrow progenitor cells.
      J L Moran, D Siegel, X M Sun and D Ross
      Molecular Pharmacology September 1996, 50 (3) 610-615;

  8. Sikela, J

    1. Functional characterization of human gamma-aminobutyric acidA receptors containing the alpha 4 subunit.
      K A Wafford, S A Thompson, D Thomas, J Sikela, A S Wilcox and P J Whiting
      Molecular Pharmacology September 1996, 50 (3) 670-678;

  9. Sivertsen, S

    1. D-penicillamine causes free radical-dependent inactivation of activator protein-1 DNA binding.
      M L Handel, C K Watts, S Sivertsen, R O Day and R L Sutherland
      Molecular Pharmacology September 1996, 50 (3) 501-505;

  10. Spiegel, S

    1. Structural requirements of sphingosylphosphocholine and sphingosine-1-phosphate for stimulation of activator protein-1 activity.
      A Berger, R Bittman, R R Schmidt and S Spiegel
      Molecular Pharmacology September 1996, 50 (3) 451-457;
« Previous (Pages : 1 2 ... 2) Next »
Back to top

In this issue

Advertisement